perioperative management of glp-1 agonists πΈ Should RAs be continued preprocedurally? πΈ Who should stop a GLP-1 RA preoperatively? πΈ Which patients should have their procedures postponed? Read: https://doi.org/10.1097/01.ASM.0001125664.22893.9f How should we approach patients
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 754.Orskov C., Poulsen S.S., Moller M., Holst J.J
Reliable operators also present currency options and show any conversion steps upfront, minimizing surprise fees

The FDA does not approve compounded medications for safety, quality, or manufacturing
This approach ensured a nuanced understanding of the genetic and demographic diversity in the cohort, enabling robust and reliable biomedical research

The FDA Adverse Event Reporting System (FAERS), a pharmacovigilance database maintained by the U.S
